Seminars in Immunology

Papers
(The TQCC of Seminars in Immunology is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Editorial Board159
Accumulation of immune-suppressive CD4 + T cells in aging – tempering inflammaging at the expense of immunity144
Differential immune responses behind different celiac disease manifestations89
Cellular stress and macrophage activation76
Myeloid derived suppressor cells in tumor microenvironment: Interaction with innate lymphoid cells64
Connecting the dots: Neutrophils at the interface of tissue regeneration and cancer61
Exploiting antifungal immunity in the clinical context58
They shall not grow mold: Soldiers of innate and adaptive immunity to fungi56
Pyroptosis modulation by bacterial effector proteins51
NGS data analysis for molecular diagnosis of Inborn Errors of Immunity49
Microbial metabolites and immunotherapy: Basic rationale and clinical indications49
Aging of lymphoid stromal architecture impacts immune responses44
Editorial Board44
Pro-resolving therapies as potential adjunct treatment for infectious diseases: Evidence from studies with annexin A1 and angiotensin-(1-7)42
Resolving inflammatory links between myocardial infarction and vascular dementia42
Immunoglobulins at the interface of the gut mycobiota and anti-fungal immunity42
Immunity to pathogenic fungi in the eye40
Seminars in immunology special issue: Nutrition, microbiota and immunity The unexplored microbes in health and disease40
Pathophysiology of neurodegenerative diseases: An interplay among axonal transport failure, oxidative stress, and inflammation?40
Different routes of MHC-I delivery to phagosomes and their consequences to CD8 T cell immunity38
Pyroptosis: A road to next-generation cancer immunotherapy37
The noncanonical inflammasome-induced pyroptosis and septic shock37
Pyroptosis and the cellular consequences of gasdermin pores36
Western diet influences on microbiome and carcinogenesis32
Introduction to the special issue: Neutrophils in the tumor microenvironment32
Interplay between the complement system and other immune pathways in the tumor microenvironment32
Beyond the Norm: The emerging interplay of complement system and extracellular matrix in the tumor microenvironment32
Immunity to fungi: Editorial overview31
Introduction to the Special Issue: Nanoparticles and immune responses30
Neuroimmune interactions between itch neurons and skin microbes29
Cellular and molecular diversity in spondyloarthritis28
The paradox of aging: Aging-related shifts in T cell function and metabolism28
Specialized pro-resolving mediators as modulators of immune responses26
The evolving biology of cross-presentation26
Adaptive NK cell response to human cytomegalovirus: Facts and open issues26
Cellular and molecular diversity in Sjogren’s syndrome salivary glands: Towards a better definition of disease subsets26
TREM2: A new player in the tumor microenvironment25
Recent developments in C3-targeted complement therapeutics25
Resolution pharmacology − A fresh approach to the clinical management of human inflammatory diseases25
Antigen discovery for the development of cancer immunotherapy24
Annexin A1 based inflammation resolving mediators and nanomedicines for inflammatory bowel disease therapy24
The dual role of neutrophils in cancer24
Thymus aging and immune reconstitution, progresses and challenges23
Introduction to the Special Issue: Nutrition, microbiota and immunity22
Sialic acid and Siglec receptors in tumor immunity and immunotherapy22
T cell control of SARS-CoV-2: When, which, and where?21
Empowering patients from within: Emerging nanomedicines for in vivo immune cell reprogramming21
Targeting the tissue-complosome for curbing inflammatory disease20
Age-dependent changes in T follicular helper cells shape the humoral immune response to vaccination20
E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinic20
Complement C3-targeted therapy in C3 glomerulopathy, a prototype of complement-mediated kidney diseases20
Individual- and population-associated heterogeneity in vaccine-induced immune responses. The impact of inflammatory status and diabetic comorbidity20
The tissue glycome as regulator of immune activation and tolerance mediated by C-type lectins and Siglecs20
Antigen cross-presentation by dendritic cells: A critical axis in cancer immunotherapy19
Activation of B cells in Tertiary Lymphoid Structures in cancer: Anti-tumor or anti-self?19
T cell fate decisions during memory cell generation with aging19
What fungal CNS infections can teach us about neuroimmunology and CNS-specific immunity19
The immunological processes behind aquaporin 4-antibody seropositive neuromyelitis optica spectrum disorders19
Cellular and molecular heterogeneity in systemic lupus erythematosus18
Immunotherapy targeting inhibitory checkpoints: The role of NK and other innate lymphoid cells18
Better safe than sorry: Naive T-cell dynamics in healthy ageing18
Publisher's note: Welcome Prof. Guido Kroemer18
Editorial Board18
The complement system in clinical oncology: Applications, limitations and challenges18
0.021223783493042